David Arkowitz, Chief Financial Officer at Flexion Therapeutics Inc (FLXN), sold 2,413 shares at $10.88 ($26K) on 2020-05-07, disclosed to the SEC on 2020-05-11.
Scheduled sale ($26k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| MCRB | SELL | 2023-10-31 | $5K | — | Filing → |
| FLXN | SELL | 2021-05-12 | $16K | — | Filing → |
| FLXN | SELL | 2021-01-07 | $135K | — | Filing → |